Largest pharmaceuticals by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 pharmaceuticals ranked by earnings, at SGD 34.6B, ahead of Eli Lilly (SGD 26.6B) and Merck & Co (SGD 23.5B). Figures as of 18 Nov 2026, 16:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonSGD 34.6B
- Median
- SGD 76.1M
- Combined market value
- SGD 6.56T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | SGD 34.6B | SGD 854.4B | SGD 354.90 | 1.26% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | SGD 26.6B | SGD 1.6T | SGD 1,791.76 | 1.85% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | SGD 23.5B | SGD 443.8B | SGD 180.02 | 2.64% down | 51% up | ||
| 4 | Novo NordiskNVO · Health Care | SGD 19.6B | SGD 226B | SGD 51.27 | 2.32% down | 17% down | ||
| 5 | NovartisNVS · Health Care | SGD 18B | SGD 380.7B | SGD 201.59 | 1.77% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | SGD 13.2B | SGD 358.2B | SGD 230.93 | 1.76% down | 2% up | ||
| 7 | SanofiSNY · Health Care | SGD 11.2B | SGD 146.4B | SGD 60.99 | 0.50% down | 4% down | ||
| 8 | PfizerPFE · Health Care | SGD 10B | SGD 207.1B | SGD 36.34 | 1.04% down | 14% up | ||
| 9 | GSKGSK · Health Care | SGD 9.8B | SGD 126.3B | SGD 63.03 | 0.75% down | 6% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | SGD 9.1B | SGD 157.9B | SGD 77.25 | 2.36% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | SGD 8.4B | SGD 232.6B | SGD 134.30 | 0.55% down | 17% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | SGD 5.8B | SGD 127.5B | SGD 1,232.51 | 0.22% down | 36% up | ||
| 13 | AbbVieABBV · Health Care | SGD 5.5B | SGD 657.5B | SGD 371.95 | 1.50% down | 26% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | SGD 5.1B | SGD 174.9B | SGD 689.86 | 0.13% up | 27% up | ||
| 15 | ZoetisZTS · Health Care | SGD 3.4B | SGD 44B | SGD 108.26 | 0.56% up | 29% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | SGD 1.8B | SGD 63.8B | SGD 54.71 | 0.47% down | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | SGD 1.7B | SGD 31.5B | SGD 740.67 | 1.68% down | 23% up | ||
| 18 | GenmabGMAB · Health Care | SGD 1.2B | SGD 40.9B | SGD 66.35 | 0.98% down | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | SGD 994.3M | SGD 50.8B | SGD 88.39 | 0.20% down | 78% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | SGD 880.4M | SGD 6.5B | SGD 78.09 | 0.31% up | 20% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 588M | SGD 16.1B | SGD 19.33 | 1.32% up | 5% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | SGD 576.7M | SGD 12.5B | SGD 82.65 | 2.20% up | 107% up | ||
| 23 | GrifolsGRFS · Health Care | SGD 575.2M | SGD 7.5B | SGD 11.03 | 0.87% down | 1% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | SGD 450M | SGD 15B | SGD 77.62 | 2.87% up | 11% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | SGD 404.6M | SGD 26.5B | SGD 197.74 | 2.03% down | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | SGD 370M | SGD 59.6B | SGD 521.75 | 2.10% down | 17% up | ||
| 27 | AlkermesALKS · Health Care | SGD 311.7M | SGD 10.1B | SGD 60.18 | 2.66% up | 58% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | SGD 160.5M | SGD 7.7B | SGD 386.57 | 2.02% up | 43% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | SGD 128.5M | SGD 9.7B | SGD 88.55 | 2.01% down | 8% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | SGD 92.9M | SGD 9.7B | SGD 27.88 | 2.37% up | 83% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 76.1M | SGD 9.8B | SGD 124.12 | 1.19% up | 126% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -SGD 2.1M | SGD 7.9B | SGD 56.04 | 1.07% up | 10% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -SGD 30.1M | SGD 7.7B | SGD 118.11 | 0.40% down | 31% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -SGD 32.9M | SGD 6.2B | SGD 64.88 | 1.55% down | 44% up | ||
| 35 | VeradermicsMANE · Health Care | -SGD 90.3M | SGD 6.8B | SGD 160.88 | 0.71% down | 233% up | ||
| 36 | Belite BioBLTE · Health Care | -SGD 100.1M | SGD 8.3B | SGD 205.26 | 0.91% up | 31% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -SGD 136M | SGD 8.5B | SGD 124.64 | 0.34% up | 241% up | ||
| 38 | ErascaERAS · Health Care | -SGD 160.6M | SGD 6B | SGD 17.09 | 4.61% down | 403% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -SGD 167.8M | SGD 10.5B | SGD 160.77 | 0.01% down | 46% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -SGD 200.2M | SGD 11.7B | SGD 122.67 | 1.40% up | 286% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -SGD 209.4M | SGD 6.3B | SGD 111.47 | 0.63% down | 113% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -SGD 216.4M | SGD 5.8B | SGD 52.59 | 3.00% down | 88% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -SGD 236.2M | SGD 9.1B | SGD 172.28 | 1.74% down | 7% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -SGD 237M | SGD 5B | SGD 36.74 | 3.03% down | 169% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -SGD 253.5M | SGD 10.4B | SGD 150.48 | 0.06% up | 13% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -SGD 299.2M | SGD 17B | SGD 34.07 | 2.21% up | 20% up | ||
| 47 | Ascendis PharmaASND · Health Care | -SGD 326.3M | SGD 22.9B | SGD 348.80 | 0.27% down | 28% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -SGD 371.8M | SGD 12.3B | SGD 531.12 | 2.41% down | 24% down | ||
| 49 | Legend BiotechLEGN · Health Care | -SGD 382.8M | SGD 4.1B | SGD 20.91 | 0.65% up | 42% down | ||
| 50 | Roivant SciencesROIV · Health Care | -SGD 386.6M | SGD 36.3B | SGD 50.09 | 0.34% up | 90% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -SGD 391.1M | SGD 11B | SGD 393.83 | 0.10% up | 61% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -SGD 424.2M | SGD 6.4B | SGD 36.89 | 2.71% up | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -SGD 459.3M | SGD 20.2B | SGD 314.38 | 1.27% up | 37% up | ||
| 54 | ABIVAXABVX · Health Care | -SGD 480.9M | SGD 9.4B | SGD 107.87 | 1.88% up | 27% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -SGD 491.9M | SGD 5.9B | SGD 35.18 | 1.19% up | 64% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -SGD 945.2M | SGD 19.6B | SGD 100.53 | 1.50% up | 17% up | ||
| 57 | CytokineticsCYTK · Health Care | -SGD 1B | SGD 9.2B | SGD 66.11 | 0.76% down | 20% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -SGD 1.2B | SGD 88.1B | SGD 27.57 | 1.22% down | 54% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -SGD 1.4B | SGD 11.2B | SGD 13.99 | 1.69% up | 36% down | ||
| 60 | InsmedINSM · Health Care | -SGD 1.6B | SGD 34B | SGD 154.77 | 1.52% down | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -SGD 4.5B | SGD 30.7B | SGD 26.74 | 1.39% up | 96% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2896 SGD).
Questions and answers
Which pharmaceuticals rank first by earnings?
Johnson & Johnson (SGD 34.6B), Eli Lilly (SGD 26.6B) and Merck & Co (SGD 23.5B) are the top three of the 61 pharmaceuticals ranked by earnings as of 18 Nov 2026, 16:06 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by earnings.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by earnings have a combined market value of SGD 6.56T as of 18 Nov 2026, 16:06 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceuticals by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.